Vincerx Pharma is a recently formed clinical-stage life sciences company focused on leveraging its extensive development and oncology.
Vincerx Pharma has raised $16.5M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in April 2024.
Vincerx Pharma is headquartered in Palo Alto, United States.
Vincerx Pharma is a recently formed clinical-stage life sciences company focused on leveraging its extensive development and oncology.
Vincerx Pharma is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Vincerx Pharma — Funding & Investors." VCBacked, April 25, 2024, https://www.vcbacked.co/company/vincerx-pharma. Accessed August 14, 2026.
VCBacked. (2024). Vincerx Pharma — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/vincerx-pharma
{{cite web |title=Vincerx Pharma — Funding & Investors |url=https://www.vcbacked.co/company/vincerx-pharma |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated